22 Jul 2020

A study exploring the feasibility of introducing OBP for new cancer medicines in the NHS, focusing on the kinds of outcomes that patients and their carers consider most important to refer to in this context.

Read the full article here.
This content was originally published by Rand Organization. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Rand Organization

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.